Balanced news tone
News Sentiment
688235 sentiment intelligence
BeOne Medicines AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-6.5% over one week, +14.8% over four weeks, trend inactive, and materially above fair value.
BeOne Medicines Ltd. Class A Actuals & Estimates (SSE:688235)
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
BeOne Medicines Ltd. Class A Actuals & Estimates (SSE:688235)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 21:57
- Source
- TradingView
BeOne Medicines Chief Executive Officer Sold Shares Worth Over $980K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- TradingView
BeOne Medicines Ltd. - American Depositary Shares (ONC) Stock Price, News, Quote & History
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 06:18
- Source
- FinancialContent
Then there were two: BeOne moves beyond single-blockbuster dependence
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- thebambooworks.com
Results: BeOne Medicines AG Beat Earnings Expectations And Analysts Now Have New Forecasts
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- simplywall.st
Amgen and BeOne Medicines get Chinese approval for small cell lung cancer drug
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 12 Apr 2026 07:00
- Source
- Mugglehead Investment Magazine
BeOne Medicines: Guidance Weighs But Multiple Catalysts In 2026 (NASDAQ:ONC)
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 28 Feb 2026 08:00
- Source
- Seeking Alpha
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Feb 2026 08:00
- Source
- Business Wire
BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Nov 2025 08:00
- Source
- Business Wire
BEONE MEDICINES LTD. (6160) - stock price, quote, history
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Aug 2018 07:00
- Source
- hkex.com.hk